Co-Founder & SVP

Dr. Ma is a co-founder and served as the founding chief executive of OmniNano until July 2024. He currently serves as SVP for Translational Science and Operations. Before joining OmniNano, Dr. Ma had been an independent consultant in the areas of biostatistics, clinical research, and regulatory strategy since 2020. Prior to that, Dr. Ma worked for Medtronic for 21 years with the increased responsibilities. For the last 11 years there, he was a senior director of clinical research for the Spine and Biologics Business (annual revenue > $3B).

Dr. Ma has extensive experiences in leading multiple functional/regional teams in clinical science, biostatistics, medical writing, scientific publications, imaging science, and global clinical trial management (US, EU, Japan, and China), as well as coordinating regulatory submissions and the development of regulatory strategies. He managed an organization of >40 employees with an annual operational budget of $20 million. He played critical roles in the premarket approval for a dozen of products by FDA, PMDA (Japan), and EMA (Europe). At Medtronic, his exceptional services were recognized by his receptions of Global Clinical Research Excellence Award and Technical Contributor of the Year Award. Dr. Ma received his PhD degree in plant genetics and master degree in statistics from Virginia Tech.